Saturday, February, 23, 2019 01:21:41

Contribution By Ojaswita Kutepatil


Lupin launches generic Tetrabenazine tablets in the United States

Lupin Limited, a renowned transnational pharmaceutical company headquartered in Mumbai, India, has reportedly announced the launch of its Tetrabenazine tablets in the U.S. Reports cite, the drug is used to treat the involuntary moments that an individual suffering from the Huntington’s disease often experiences. The …

Roche, Ascletis team up to expand viral Hepatitis treatment in China

Swiss healthcare conglomerate, Roche AG’s Chinese arm Shanghai Roche Pharmaceuticals Ltd. has recently announced collaboration with biotechnology firm Ascletis BioScience Co., Ltd to expand their partnership on a pegylated interferon treatment (deemed Pegasys) for Hepatitis B and C starting December 2018. As per trusted sources, …

WUSTL’s revolutionary technique to enable drug delivery to the brain

St. Louis based Washington University’s researchers have reportedly established a new technique to overcome the blood-brain barrier (BBB), in a bid to administer medications to the brain. Sources familiar with the development claim that these medications would particularly heal brain tumors classified under the difficult-to-treat …